Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.53 |
| ▸ | TERT | O14746 | 3/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.53 |
| ▸ | PPARG | P37231 | 3/20 | 0.53 |
| ▸ | PPARD | Q03181 | 3/20 | 0.53 |
| ▸ | PPARA | Q07869 | 3/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.53 |
| ▸ | BLM | P54132 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | FABP4 | P15090 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | TOP1 | P11387 | 2/20 | 0.53 |
| ▸ | GMNN | O75496 | 1/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19643384 | 1.00 | FAAH (0.53) | FAAHTERTPTPN1PPARGPPARD | |
| SCHEMBL3506667 | 1.00 | FAAH (0.53) | FAAHTERTPTPN1PPARGPPARD | |
| SCHEMBL1301610 | 1.00 | FAAH (0.53) | FAAHTERTPTPN1PPARGPPARD | |
| SCHEMBL1301613 | 1.00 | FAAH (0.53) | FAAHTERTPTPN1PPARGPPARD | |
| SCHEMBL18837285 | 1.00 | FAAH (0.53) | FAAHTERTPTPN1PPARGPPARD | |
| SCHEMBL1302485 | 1.00 | FAAH (0.53) | FAAHTERTPTPN1PPARGPPARD | |
| SCHEMBL1302487 | 1.00 | FAAH (0.53) | FAAHTERTPTPN1PPARGPPARD | |
| SCHEMBL1302086 | 1.00 | FAAH (0.53) | FAAHTERTPTPN1PPARGPPARD | |
| SCHEMBL10386003 | 1.00 | FAAH (0.53) | FAAHTERTPTPN1PPARGPPARD | |
| SCHEMBL10385996 | 1.00 | FAAH (0.53) | FAAHTERTPTPN1PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4501901-A2 | RUTHENIUM COMPLEXES USEFUL FOR CATALYZING METATHESIS REACTIONS | Verbio SE (DE) | 2025-02-05 | — | — | EP | disclosed |
| EP-3865495-B1 | RUTHENIUM COMPLEXES USEFUL FOR CATALYZING METATHESIS REACTIONS | VERBIO VER BIOENERGIE AG (DE) | 2024-10-09 | — | — | EP | disclosed |
| US-11484873-B2 | Ruthenium complexes useful for catalyzing metathesis reactions | VERBIO VEREINIGTE BIOENERGIE AG (DE) | 2022-11-01 | — | — | US | disclosed |
| EP-3865495-A2 | RUTHENIUM COMPLEXES USEFUL FOR CATALYZING METATHESIS REACTIONS | Verbio Vereinigte BioEnergie AG (DE) | 2021-08-18 | — | — | EP | disclosed |
| EP-3538508-B1 | RUTHENIUM COMPLEXES USEFUL FOR CATALYZING METATHESIS REACTIONS | VERBIO VER BIOENERGIE AG (DE) | 2021-04-14 | — | — | EP | disclosed |
| US-20200282386-A1 | RUTHENIUM COMPLEXES USEFUL FOR CATALYZING METATHESIS REACTIONS | VERBIO SE (DE) | 2020-09-10 | — | — | US | disclosed |
| US-10688481-B2 | Ruthenium complexes useful for catalyzing metathesis reactions | XIMO AG (DE) | 2020-06-23 | — | — | US | disclosed |
| US-10688481-B2 | Ruthenium complexes useful for catalyzing metathesis reactions | XIMO AG (DE) | 2020-06-23 | — | — | US | disclosed |
| EP-3538508-A1 | RUTHENIUM COMPLEXES USEFUL FOR CATALYZING METATHESIS REACTIONS | XiMo AG (CH) | 2019-09-18 | — | — | EP | disclosed |
| US-20190210012-A1 | RUTHENIUM COMPLEXES USEFUL FOR CATALYZING METATHESIS REACTIONS | VERBIO SE (DE) | 2019-07-11 | — | — | US | disclosed |
| US-20190210012-A1 | RUTHENIUM COMPLEXES USEFUL FOR CATALYZING METATHESIS REACTIONS | VERBIO SE (DE) | 2019-07-11 | — | — | US | disclosed |
| WO-2018087230-A1 | RUTHENIUM COMPLEXES USEFUL FOR CATALYZING METATHESIS REACTIONS | XIMO AG (CH) | 2018-05-17 | — | — | WO | disclosed |
| US-3962321-A | ADDING A PYRAZINE AND 2-NONENAL ANDOR 2-NONENOL | GENERAL FOODS CORPORATION (US) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200282386-A1 | RUTHENIUM COMPLEXES USEFUL FOR CATALYZING METATHESIS REACTIONS | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, RFC1, RFC5 | FAAH 2644/4885TERT 1193/4885PTPN1 3007/4885 |
| US-10688481-B2 | Ruthenium complexes useful for catalyzing metathesis reactions | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR3, RFC1 | FAAH 2530/4885TERT 834/4885PTPN1 3516/4885 |
| US-20190210012-A1 | RUTHENIUM COMPLEXES USEFUL FOR CATALYZING METATHESIS REACTIONS | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CBR3, RFC1 | FAAH 2530/4885TERT 834/4885PTPN1 3516/4885 |
| US-11484873-B2 | Ruthenium complexes useful for catalyzing metathesis reactions | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, RFC1, RFC5 | FAAH 2644/4885TERT 1193/4885PTPN1 3007/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.